Retatrutide
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
HPLC-verified Retatrutide for laboratory research, dispatched from Sydney with a Certificate of Analysis on every tested batch.
Retatrutide is a synthetic, single-molecule peptide studied as a triple agonist of the GIP, GLP-1 and glucagon receptors. In laboratory research it is investigated for its combined influence on glucose regulation, lipid metabolism and energy-expenditure pathways in pre-clinical and in-vitro models. Because it engages three incretin and metabolic receptors at once, it is of particular interest to researchers comparing multi-agonist pharmacology against single- and dual-receptor peptides.
Reproducible research depends on knowing exactly what is in the vial. A peptide that is mislabelled, impure, or contaminated with endotoxin undermines experimental results and wastes time. That is why every Retatrutide batch we supply is characterised before it is listed: reversed-phase HPLC quantifies main-peak purity to a ≥99.0% specification, mass spectrometry confirms the molecular weight matches the theoretical value, and an LAL gel-clot assay screens for bacterial endotoxin. The Certificate of Analysis for the batch is published on the product page so you can see the actual results for the lot you receive.
Retatrutide is offered from 10mg up to 60mg per vial. The 10mg vial is the standard research starting point; larger dosages suit higher-throughput or longer research programmes. Every dosage is available as a single vial or a 10-vial pack, with the pack priced 5% below ten singles. Pricing scales consistently with dosage so larger vials always represent more material per dollar.
Choose your dosage and pack size on the Retatrutide product page, add it to your cart, and check out securely. Reconstitution requires bacteriostatic water, which you can add to the same order. If you are new to ordering research peptides, our Australian buyers’ guide and supplier-verification guide walk through what to check.
An investigational triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
Retatrutide is supplied for in-vitro laboratory research only, not for human use. Regulations governing research chemicals vary by jurisdiction, and it is the buyer’s responsibility to ensure their purchase and use comply with local law. We do not provide legal advice.
Each batch is analysed by reversed-phase HPLC to a specification of ≥99.0% purity, with mass-spectrometry identity confirmation and LAL endotoxin screening. The Certificate of Analysis for the batch is available on the product page.
Orders are dispatched from Sydney in plain, protective packaging with tracking. Australian delivery is typically 2–5 business days; international orders ship worldwide. Current delivery is around 2 weeks due to high demand.
Retatrutide is available from 10mg through 60mg per vial, each as a single vial or a 10-vial pack (save 5%). See the product page for the full variant list and pricing.
HPLC-verified Retatrutide with a Certificate of Analysis on every tested batch. Secure checkout in AUD.
View Retatrutide →